Medicenna Therapeutics Dividends
MDNA Stock | CAD 1.72 0.06 3.37% |
As of the 2nd of December 2024, Dividend Paid And Capex Coverage Ratio is likely to drop to -1,638. Medicenna Therapeutics' past performance could be the main factor of why investors trade Medicenna Therapeutics Corp stock today. Investors should clearly understand every aspect of the Medicenna Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Medicenna Therapeutics' dividend schedule and payout information. Medicenna Therapeutics Corp dividends can also provide a clue to the current valuation of Medicenna Therapeutics.
Last Reported | Projected for Next Year | ||
Dividend Paid And Capex Coverage Ratio | -1.6 K | -1.6 K |
Medicenna |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Medicenna Therapeutics must own a stock before its ex-dividend date to receive its next dividend.